Other Species / Isoforms
  NEK9 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2
______MsVLGEYER
0 9
NEK9 (human) ______MsVLGEYER S2
NEK9 (mouse) ______MsVLGEYER S2
NEK9 (rat) ______MSVLGEYER S2
S13
EYERHCDsINsDFGs
0 9
NEK9 (human) EYERHCDsINsDFGs S13
NEK9 (mouse) EYERHCDsINsDFGs S13
NEK9 (rat) EYERHCDSINSDFGS S13
S16
RHCDsINsDFGsEsG
0 6
NEK9 (human) RHCDsINsDFGsEsG S16
NEK9 (mouse) RHCDsINsDFGsEsG S16
NEK9 (rat) RHCDSINSDFGSESG S16
S20
sINsDFGsEsGGGGD
0 5
NEK9 (human) sINsDFGsEsGGCGD S20
NEK9 (mouse) sINsDFGsEsGGGGD S20
NEK9 (rat) SINSDFGSESGGGGD S20
S22
NsDFGsEsGGGGDsG
Upstream
0 2
Treatment
  • insulin
  • MK-2206
NEK9 (human) NsDFGsEsGGCGDss S22
NEK9 (mouse) NsDFGsEsGGGGDsG S22
NEK9 (rat) NSDFGSESGGGGDSG S22
S28
EsGGGGDsGPGPSAV
Upstream
0 2
Treatment
  • insulin
NEK9 (human) EsGGCGDssPGPSAs S28
NEK9 (mouse) EsGGGGDsGPGPSAV S28
NEK9 (rat) ESGGGGDSGSGPSAS S28
G29
sGGGGDsGPGPSAVP
1 13
NEK9 (human) sGGCGDssPGPSAsQ S29
NEK9 (mouse) sGGGGDsGPGPSAVP G29
NEK9 (rat) SGGGGDSGSGPSASP G29
V35
sGPGPSAVPGPRAGG
0 2
NEK9 (human) ssPGPSAsQGPRAGG S35
NEK9 (mouse) sGPGPSAVPGPRAGG V35
NEK9 (rat) SGSGPSASPGPRAGG S35
Y52
AEQEELHYIPIRVLG
0 5
NEK9 (human) AEQEELHyIPIRVLG Y52
NEK9 (mouse) AEQEELHYIPIRVLG Y52
NEK9 (rat) AEQEELHYIPIRVLG Y51
T72
EATLYRRTEDDSLVV
0 1
NEK9 (human) EATLYRRtEDDsLVV T72
NEK9 (mouse) EATLYRRTEDDSLVV T72
NEK9 (rat) EATLYRRTEDDSLVV T71
S76
YRRTEDDSLVVWKEV
0 4
NEK9 (human) YRRtEDDsLVVWKEV S76
NEK9 (mouse) YRRTEDDSLVVWKEV S76
NEK9 (rat) YRRTEDDSLVVWKEV S75
S206
KKLNSEYSMAETLVG
0 1
NEK9 (human) KKLNSEYsMAEtLVG S206
NEK9 (mouse) KKLNSEYSMAETLVG S206
NEK9 (rat) KKLNSEYSMAETLVG S205
T210
SEYSMAETLVGTPYY
4 0
NEK9 (human) SEYsMAEtLVGtPYY T210
NEK9 (mouse) SEYSMAETLVGTPYY T210
NEK9 (rat) SEYSMAETLVGTPYY T209
T214
MAETLVGTPYYMSPE
0 1
NEK9 (human) MAEtLVGtPYYMSPE T214
NEK9 (mouse) MAETLVGTPYYMSPE T214
NEK9 (rat) MAETLVGTPYYMSPE T213
T254
LKRTFDAtNPLNLCV
0 8
NEK9 (human) LKRTFDAtNPLNLCV T254
NEK9 (mouse) LKRTFDAtNPLNLCV T254
NEK9 (rat) LKRTFDATNPLNLCV T253
T326
VTLLNAPTKRPRsst
0 2
NEK9 (human) VTLLNAPtKRPRsst T326
NEK9 (mouse) VTLLNAPTKRPRsst T326
NEK9 (rat) VTLLNAPTKRPRsst T325
S331
APTKRPRsstVtEAP
0 36
NEK9 (human) APtKRPRsstVtEAP S331
NEK9 (mouse) APTKRPRsstVtEAP S331
NEK9 (rat) APTKRPRsstVTEAP S330
S332
PTKRPRsstVtEAPI
0 69
NEK9 (human) PtKRPRsstVtEAPI S332
NEK9 (mouse) PTKRPRsstVtEAPI S332
NEK9 (rat) PTKRPRsstVTEAPI S331
T333
TKRPRsstVtEAPIA
Upstream
1 189
Treatment
  • GSK2334470
  • insulin
  • LY294002
  • MK-2206
  • Torin1
NEK9 (human) tKRPRsstVtEAPIA T333
NEK9 (mouse) TKRPRsstVtEAPIA T333
NEK9 (rat) TKRPRsstVTEAPIA T332
T335
RPRsstVtEAPIAVV
Upstream
0 13
Treatment
  • LPA
NEK9 (human) RPRsstVtEAPIAVV T335
NEK9 (mouse) RPRsstVtEAPIAVV T335
NEK9 (rat) RPRsstVTEAPIAVV T334
Y350
TSRTSEVYVWGGGKS
0 1
NEK9 (human) TSRTSEVyVWGGGKs Y350
NEK9 (mouse) TSRTSEVYVWGGGKS Y350
NEK9 (rat) TSRTSEVYVWGGGKS Y349
S357
YVWGGGKStPQKLDV
0 1
NEK9 (human) yVWGGGKstPQKLDV S357
NEK9 (mouse) YVWGGGKStPQKLDV S357
NEK9 (rat) YVWGGGKSTPQKLDV S356
T358
VWGGGKStPQKLDVI
0 10
NEK9 (human) VWGGGKstPQKLDVI T358
NEK9 (mouse) VWGGGKStPQKLDVI T358
NEK9 (rat) VWGGGKSTPQKLDVI T357
S367
QKLDVIKsGCsARQV
0 1
NEK9 (human) QKLDVIKSGCSARQV S367
NEK9 (mouse) QKLDVIKsGCsARQV S367
NEK9 (rat) QKLDVIKSGCSARQV S366
S370
DVIKsGCsARQVCAG
0 1
NEK9 (human) DVIKSGCSARQVCAG S370
NEK9 (mouse) DVIKsGCsARQVCAG S370
NEK9 (rat) DVIKSGCSARQVCAG S369
T379
RQVCAGNtHFAVVTV
0 1
NEK9 (human) RQVCAGNTHFAVVTV T379
NEK9 (mouse) RQVCAGNtHFAVVTV T379
NEK9 (rat) RQVCAGNTHFAVVTV T378
S413
LGHGDKASYRQPKHV
0 1
NEK9 (human) LGHGDKAsYRQPKHV S413
NEK9 (mouse) LGHGDKASYRQPKHV S413
NEK9 (rat) LGHGDKASYRQPKHV S412
Y509
YSWGCGEyGRLGLDS
0 2
NEK9 (human) YSWGCGEyGRLGLDs Y509
NEK9 (mouse) YSWGCGEyGRLGLDS Y509
NEK9 (rat) YSWGCGEYGRLGLDS Y508
S516
yGRLGLDSEEDYYTP
0 1
NEK9 (human) yGRLGLDsEEDyYTP S516
NEK9 (mouse) yGRLGLDSEEDYYTP S516
NEK9 (rat) YGRLGLDSEEDYYTP S515
Y520
GLDSEEDYYTPQRVD
0 7
NEK9 (human) GLDsEEDyYTPQKVD Y520
NEK9 (mouse) GLDSEEDYYTPQRVD Y520
NEK9 (rat) GLDSEEDYYTPQRVD Y519
T685
GNGRLAMTPTERPHG
0 1
NEK9 (human) GNGRLAMtPTERPHG T685
NEK9 (mouse) GNGRLAMTPTERPHG T685
NEK9 (rat) GNGRLAMTPTERPHG T684
T732
EKVLNSKTIRSNSSG
0 1
NEK9 (human) EKVLNSKtIRsNSSG T732
NEK9 (mouse) EKVLNSKTIRSNSSG T732
NEK9 (rat) EKVLNSKTIRSNsSG T731
S735
LNSKTIRSNSSGLsI
0 1
NEK9 (human) LNSKtIRsNSSGLsI S735
NEK9 (mouse) LNSKTIRSNSSGLsI S735
NEK9 (rat) LNSKTIRSNsSGLSI S734
S737
SKTIRSNSSGLsIGT
0 1
NEK9 (human) SKtIRsNSSGLsIGT S737
NEK9 (mouse) SKTIRSNSSGLsIGT S737
NEK9 (rat) SKTIRSNsSGLSIGT S736
S741
RSNSSGLsIGTVVQS
0 2
NEK9 (human) RsNSSGLsIGTVFQS S741
NEK9 (mouse) RSNSSGLsIGTVVQS S741
NEK9 (rat) RSNsSGLSIGTVVQS S740
S750
GTVVQSSSPGGGIGG
1 2
NEK9 (human) GTVFQSSsPGGGGGG S750
NEK9 (mouse) GTVVQSSSPGGGIGG S750
NEK9 (rat) GTVVQSSSPGGRIGG S749
S800
RGMEGLIsPtEAVGN
0 5
NEK9 (human) RGMEGLIsPtEAMGN S793
NEK9 (mouse) RGMEGLIsPtEAVGN S800
NEK9 (rat) RGMEGLISPTEAVGN S792
T802
MEGLIsPtEAVGNsC
0 2
NEK9 (human) MEGLIsPtEAMGNsN T795
NEK9 (mouse) MEGLIsPtEAVGNsC T802
NEK9 (rat) MEGLISPTEAVGNSC T794
S808
PtEAVGNsCGASSSC
0 5
NEK9 (human) PtEAMGNsNGASSSC S801
NEK9 (mouse) PtEAVGNsCGASSSC S808
NEK9 (rat) PTEAVGNSCGASSSC S800
S834
EFIPMPDsPAPLsAA
Upstream
0 10
Treatment
  • insulin
NEK9 (human) EFIPMPDsPsPLsAA S827
NEK9 (mouse) EFIPMPDsPAPLsAA S834
NEK9 (rat) EFIPMPDsPTPLSAA S826
A836
IPMPDsPAPLsAAFS
0 3
NEK9 (human) IPMPDsPsPLsAAFs S829
NEK9 (mouse) IPMPDsPAPLsAAFS A836
NEK9 (rat) IPMPDsPTPLSAAFS T828
S839
PDsPAPLsAAFSQSE
Upstream
0 4
Treatment
  • insulin
NEK9 (human) PDsPsPLsAAFsEsE S832
NEK9 (mouse) PDsPAPLsAAFSQSE S839
NEK9 (rat) PDsPTPLSAAFSQSE S831
S843
APLsAAFSQSEKDTL
0 3
NEK9 (human) sPLsAAFsEsEKDtL S836
NEK9 (mouse) APLsAAFSQSEKDTL S843
NEK9 (rat) TPLSAAFSQSEKDTL S835
S845
LsAAFSQSEKDTLPY
0 2
NEK9 (human) LsAAFsEsEKDtLPy S838
NEK9 (mouse) LsAAFSQSEKDTLPY S845
NEK9 (rat) LSAAFSQSEKDTLPY S837
T849
FSQSEKDTLPYEELQ
0 3
NEK9 (human) FsEsEKDtLPyEELQ T842
NEK9 (mouse) FSQSEKDTLPYEELQ T849
NEK9 (rat) FSQSEKDTLPYEELQ T841
Y852
SEKDTLPYEELQGLK
0 53
NEK9 (human) sEKDtLPyEELQGLK Y845
NEK9 (mouse) SEKDTLPYEELQGLK Y852
NEK9 (rat) SEKDTLPYEELQGLK Y844
S862
LQGLKVASEVPPEPQ
0 4
NEK9 (human) LQGLKVAsEAPLEHK S855
NEK9 (mouse) LQGLKVASEVPPEPQ S862
NEK9 (rat) LQGLKVASEVPPEHQ S854
W875
PQRAAGAWPPRLDPA
0 15
NEK9 (human) HKPQVEAssPRLNPA S868
NEK9 (mouse) PQRAAGAWPPRLDPA W875
NEK9 (rat) HQPAVGAWPPRLNPA W867
P876
QRAAGAWPPRLDPAV
1 16
NEK9 (human) KPQVEAssPRLNPAV S869
NEK9 (mouse) QRAAGAWPPRLDPAV P876
NEK9 (rat) QPAVGAWPPRLNPAV P868
P884
PRLDPAVPCVGKALT
0 2
NEK9 (human) PRLNPAVtCAGKGtP T877
NEK9 (mouse) PRLDPAVPCVGKALT P884
NEK9 (rat) PRLNPAVPCVGKALT P876
-
gap
0 2
NEK9 (human) VtCAGKGtPLtPPAC T883
NEK9 (mouse) gap -
NEK9 (rat) gap -
T891
PCVGKALTSAACACS
0 11
NEK9 (human) AGKGtPLtPPACACS T886
NEK9 (mouse) PCVGKALTSAACACS T891
NEK9 (rat) PCVGKALTSPACACS T883
S949
GQQVGMHsRGTQTAK
Upstream
1 11
Treatment
  • ischemia
NEK9 (human) GQQVGMHsKGTQTAK S944
NEK9 (mouse) GQQVGMHsRGTQTAK S949
NEK9 (rat) GQQVGMHSRGTQTAK S941
S983
GTDSCRPSL______
0 8
NEK9 (human) GTDSCRPsL______ S978
NEK9 (mouse) GTDSCRPSL______ S983
NEK9 (rat) gap -